Avidity Biosciences
103 hedge funds and large institutions have $1.09B invested in Avidity Biosciences in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 107 → 103 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
Holders
103
Holding in Top 10
2
Calls
$2.72M
Puts
$5K
Top Buyers
| 1 | +$204M | |
| 2 | +$32.2M | |
| 3 | +$5.44M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.69M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.52M |
Top Sellers
| 1 | -$23.8M | |
| 2 | -$3.04M | |
| 3 | -$2.55M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.31M |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
-$1.28M |